Acute biliaring infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Acute biliary infection
Exclusion criteria
Exclusion criteria: 1)History of hypersensitivity to DRPM 2)Serious complications 3)Serious cardiac disfunctions 4)Serious renal disfunctions 5)With CNS disorder 6)History of hypersensitivity to B-lactam antibiotics 7)Pregnant or lactating women and women who may be pregnant 8)MRSA infection 9)Judged by investigator not to be appropriate for inclusion in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical effectiveness | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical effectiveness at 3,7days Safety(moniterd clinical and laboratory evaluation) | — |
Countries
Japan
Contacts
graduate school of biomedicalscience, Hiroshima university. Department of General Medicine